Research Paper Volume 14, Issue 2 pp 907—922

A radiomics model predicts the response of patients with advanced gastric cancer to PD-1 inhibitor treatment


Figure 7. A decision curve was applied to compare the difference in net benefit of the clinical model and radiomics model in the validation cohort. X-axis means threshold probability, Y-axis means net benefit. The decision curve showed that when the threshold probability exceeds 10%, and the net benefit of clinical application in radiomics model would exceed the clinical model.